Coulsdon, United Kingdom

John B Harbridge


Average Co-Inventor Count = 1.3

ph-index = 3

Forward Citations = 18(Granted Patents)


Location History:

  • Coulsdon, EN (1976 - 1978)
  • Coulsdon, GB (1981 - 1987)
  • Redhill, GB (1986 - 1987)

Company Filing History:


Years Active: 1976-1987

Loading Chart...
16 patents (USPTO):Explore Patents

Title: An Insight into the Innovations of John B. Harbridge

Introduction

John B. Harbridge is a notable inventor based in Coulsdon, GB, renowned for his significant contributions to the field of pharmaceuticals and organic chemistry. With a remarkable portfolio of 16 patents, Harbridge has made strides in developing innovative compounds with potential applications in medicine.

Latest Patents

Among his latest patents is the "Deadcat reaction for making 9-deoxy-9-isocyanato clavulanates." This invention focuses on a compound of a specific formula and encompasses the processes for the preparation of these compounds. Additionally, the use of these compounds in preparing further bicyclic compounds is disclosed. Another recent innovation by Harbridge includes A-deoxy-a-aza derivatives of clavulanic acid, which detailed compounds of another specific formula. These derivatives have been identified as β-lactamase inhibitors and antibacterial agents, highlighting their therapeutic potential.

Career Highlights

John B. Harbridge has built his career at Beecham Group Plc, where he has utilized his expertise to drive advancements in pharmaceutical research. His work primarily revolves around developing new compounds with medicinal applications, showcasing his commitment to improving healthcare through innovation.

Collaborations

Throughout his career, Harbridge has collaborated with esteemed colleagues, including Irene Stirling and Thomas T. Howarth. These partnerships have played a crucial role in enhancing the development process of his inventions, facilitating a broader scope of research and innovation within the team.

Conclusion

John B. Harbridge remains a pivotal figure in the realm of pharmaceuticals, with a strong emphasis on creating compounds that serve crucial medical purposes. His dedication to innovation and collaboration within the Beecham Group continues to influence the industry positively, making significant strides toward addressing healthcare challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…